Comparison of the Action of the Rosiglitazone-Metformin Fixed-Dose Combination and of a Metformin-Sulfonylurea Free Combination on the b-Cell Function in Type 2 Diabetic Patients Not Controlled With Metformin Alone.
Phase of Trial: Phase IV
Latest Information Update: 20 Jul 2010
At a glance
- Drugs Gliclazide; Metformin; Rosiglitazone/metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 27 Oct 2008 Status changed from active, no longer recruiting to completed according to Clinicaltrials.gov record.
- 07 Nov 2006 New trial record.